New hope for Tough-to-Treat lymphoma: experimental combo aims to control disease
NCT ID NCT05852717
Summary
This study is testing whether adding a new drug called epcoritamab to a standard chemotherapy regimen (GDP) is safe and effective for adults whose large B-cell lymphoma has returned or stopped responding to prior treatment. The goal is to control the cancer and see if patients can then proceed to more definitive treatments like stem cell transplant or CAR T-cell therapy. Researchers will measure how many patients achieve complete remission after three cycles of the combination therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
RECRUITINGIndianapolis, Indiana, 46202, United States
Contact Email: •••••@•••••
Contact
-
Karmanos Cancer Center (Wayne State University)
RECRUITINGDetroit, Michigan, 48201, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Texas Southwestern Medical Center
RECRUITINGDallas, Texas, 75390, United States
Contact
Contact Email: •••••@•••••
-
University of Virginia Health System
RECRUITINGCharlottesville, Virginia, 22908, United States
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.